ASPIRA PATHLAB & DIAGNOSTICS
Back to Cashflow Statement
|
ASPIRA PATHLAB & DIAGNOSTICS Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | |
|---|---|---|
| Cash Flow from Financing Activities | ₹-0.99 Cr | ₹-0.95 Cr |
What is the latest Cash Flow from Financing Activities ratio of ASPIRA PATHLAB & DIAGNOSTICS ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹-0.99 Cr |
| Mar2024 | ₹-0.95 Cr |
How is Cash Flow from Financing Activities of ASPIRA PATHLAB & DIAGNOSTICS Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹-0.99 Cr | Negative | |
| Mar2024 | ₹-0.95 Cr | - | |
Compare Cash Flow from Financing Activities of peers of ASPIRA PATHLAB & DIAGNOSTICS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| ASPIRA PATHLAB & DIAGNOSTICS | ₹128.8 Cr | 3.9% | -3.8% | 92.6% | Stock Analytics | |
| APOLLO HOSPITALS ENTERPRISE | ₹112,152.0 Cr | 2.6% | -12.4% | -2.5% | Stock Analytics | |
| MAX HEALTHCARE INSTITUTE | ₹82,536.7 Cr | 3.4% | -19.1% | -31% | Stock Analytics | |
| ASTER DM HEALTHCARE | ₹57,935.7 Cr | 2.3% | -13.5% | -9.8% | Stock Analytics | |
| FORTIS HEALTHCARE | ₹56,089.6 Cr | 2.1% | -15.5% | -32.9% | Stock Analytics | |
| NARAYANA HRUDAYALAYA | ₹35,079.6 Cr | -0.5% | -8.6% | -5.7% | Stock Analytics | |
ASPIRA PATHLAB & DIAGNOSTICS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| ASPIRA PATHLAB & DIAGNOSTICS | 3.9% |
-3.8% |
92.6% |
| SENSEX | -0.3% |
-1.6% |
-12.3% |
You may also like the below Video Courses